Transcatheter aortic valve implantation has revolutionized the treatment of aortic stenosis since the first procedure in 2002 and it has now been widely adopted throughout the world as a minimally invasive valve replacement option when compared to conventional open heart surgery. Once a procedure only for extreme risk or non-surgical patients, randomized data have shown similar results to surgery for low surgical risk patients, and the procedure has even been performed on a day case basis in selected patients. Over 350000 operations have been performed and its use continues to expand rapidly worldwide.
We would like to draw on our existing contacts to describe the current remaining challenges of TAVI and the future directions needed to overcome them. These could include new valve designs to minimal the well known complications that still occur, refinements to implantation methods to enable future coronary access and preprocedural planning including the use of CT scanning protocols for high risk cases. We would also like to cover new surgical equipment that help minimise vascular complications and speed up recovery as well.
We would like to draw on our existing contacts to describe the current remaining challenges of TAVI and the future directions needed to overcome them. These could include:
1) New valve designs to minimal the well known complications that still occur.
2) Refinements to implantation methods to enable future coronary access and preprocedural planning including the use of CT scanning protocols for high risk cases.
3) We would also like to cover new surgical equipment that help minimise vascular complications and speed up recovery as well.
Transcatheter aortic valve implantation has revolutionized the treatment of aortic stenosis since the first procedure in 2002 and it has now been widely adopted throughout the world as a minimally invasive valve replacement option when compared to conventional open heart surgery. Once a procedure only for extreme risk or non-surgical patients, randomized data have shown similar results to surgery for low surgical risk patients, and the procedure has even been performed on a day case basis in selected patients. Over 350000 operations have been performed and its use continues to expand rapidly worldwide.
We would like to draw on our existing contacts to describe the current remaining challenges of TAVI and the future directions needed to overcome them. These could include new valve designs to minimal the well known complications that still occur, refinements to implantation methods to enable future coronary access and preprocedural planning including the use of CT scanning protocols for high risk cases. We would also like to cover new surgical equipment that help minimise vascular complications and speed up recovery as well.
We would like to draw on our existing contacts to describe the current remaining challenges of TAVI and the future directions needed to overcome them. These could include:
1) New valve designs to minimal the well known complications that still occur.
2) Refinements to implantation methods to enable future coronary access and preprocedural planning including the use of CT scanning protocols for high risk cases.
3) We would also like to cover new surgical equipment that help minimise vascular complications and speed up recovery as well.
